adenine has been researched along with Smith-Magenis Syndrome in 11 studies
Smith-Magenis Syndrome: Complex neurobehavioral disorder characterized by distinctive facial features (FACIES), developmental delay and INTELLECTUAL DISABILITY. Behavioral phenotypes include sleep disturbance, maladaptive, self-injurious and attention-seeking behaviors. The sleep disturbance is linked to an abnormal circadian secretion pattern of MELATONIN. The syndrome is associated with de novo deletion or mutation and HAPLOINSUFFICIENCY of the retinoic acid-induced 1 protein on chromosome 17p11.2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment landscape of chronic lymphocytic leukemia (CLL) has changed dramatically in the last few years." | 2.58 | Selecting Frontline Therapy for CLL in 2018. ( Jain, N, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, SJ | 1 |
| Gerrie, AS | 1 |
| Young, S | 1 |
| Tucker, T | 1 |
| Bruyere, H | 1 |
| Hrynchak, M | 1 |
| Galbraith, P | 1 |
| Al Tourah, AJ | 1 |
| Dueck, G | 1 |
| Noble, MC | 1 |
| Ramadan, KM | 1 |
| Tsang, P | 1 |
| Hardy, E | 1 |
| Sehn, L | 1 |
| Toze, CL | 1 |
| Cramer, P | 1 |
| von Tresckow, J | 1 |
| Eichhorst, B | 1 |
| Hallek, M | 2 |
| Rafei, H | 1 |
| Kharfan-Dabaja, MA | 2 |
| Davids, MS | 1 |
| Allan, JN | 1 |
| Furman, RR | 2 |
| Jones, J | 1 |
| Mato, A | 1 |
| Coutre, S | 2 |
| Byrd, JC | 1 |
| Hillmen, P | 1 |
| Osterborg, A | 1 |
| Tam, C | 1 |
| Stilgenbauer, S | 1 |
| Wierda, WG | 1 |
| Heerema, NA | 1 |
| Eckert, K | 1 |
| Clow, F | 1 |
| Zhou, C | 1 |
| Chu, AD | 1 |
| James, DF | 1 |
| O'Brien, SM | 1 |
| Barnes, JI | 1 |
| Divi, V | 1 |
| Begaye, A | 1 |
| Wong, R | 1 |
| Owens, DK | 1 |
| Goldhaber-Fiebert, JD | 1 |
| Jain, N | 1 |
| Mannis, G | 1 |
| Wu, D | 1 |
| Dea, T | 1 |
| Mauro, T | 1 |
| Hsu, G | 1 |
| El-Asmar, J | 1 |
| Awan, FT | 1 |
| Hamadani, M | 1 |
| Ayala, E | 1 |
7 reviews available for adenine and Smith-Magenis Syndrome
| Article | Year |
|---|---|
[Current diagnosis and treatment of chronic lymphocytic leukaemia].
Topics: Adenine; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemother | 2020 |
Treatment of Del17p and/or aberrant TP53 chronic lymphocytic leukemia in the era of novel therapies.
Topics: Adenine; Allografts; Bridged Bicyclo Compounds, Heterocyclic; Chromosome Deletion; Chromosomes, Huma | 2018 |
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.
Topics: Adenine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemothe | 2017 |
How should we sequence and combine novel therapies in CLL?
Topics: Adenine; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biomarkers, Tumor; Bridged Bicycl | 2017 |
Optimal management of the young patient CLL patient.
Topics: Adenine; Age Factors; Chromosome Deletion; Chromosomes, Human, Pair 17; Humans; Immunotherapy; Leuke | 2018 |
Selecting Frontline Therapy for CLL in 2018.
Topics: Adenine; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Chromosome Delet | 2018 |
Current state of hematopoietic cell transplantation in CLL as smart therapies emerge.
Topics: Adenine; Allografts; Antibodies, Monoclonal; Antibodies, Neoplasm; Bridged Bicyclo Compounds, Hetero | 2016 |
1 trial available for adenine and Smith-Magenis Syndrome
| Article | Year |
|---|---|
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials.
Topics: Adenine; Adult; Aftercare; Aged; Aged, 80 and over; Chromosome Deletion; Chromosomes, Human, Pair 17 | 2018 |
3 other studies available for adenine and Smith-Magenis Syndrome
| Article | Year |
|---|---|
Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; British Col | 2020 |
Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p.
Topics: Adenine; Aged; Chromosome Deletion; Chromosomes, Human, Pair 17; Costs and Cost Analysis; Female; Hu | 2018 |
Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia.
Topics: Adenine; Aged; Allopurinol; Antimetabolites; Antineoplastic Agents; Chromosome Deletion; Chromosomes | 2015 |